In our previous screening of ABCA7 in a European cohort of 928 EOAD patients, we observed the p.G1820S mutation in a Swedish AD-patient of 64 years old (APOE ε33) while it was absent in 980 control individuals [11]. This evidence concerns the gene APOE and Alzheimer disease.